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Abstract
Background: Laminins are a group of proteins largely responsible for the anchorage of cells to
basement membranes. We hypothesized that altered Laminin chain production in the bronchial
mucosa might explain the phenomenon of epithelial cell shedding in asthma. The aim was to
characterize the presence of Laminin chains in the SEBM and epithelium in allergic and non-allergic
asthmatics.
Patients and methods: Biopsies were taken from the bronchi of 11 patients with allergic and 9
patients with non-allergic asthma and from 7 controls and stained with antibodies against the
Laminin (ln) chains alpha1-alpha5, beta1-beta2 and gamma1-gamma2.
Results: Lns-2,-5 and -10 were the main Laminins of SEBM. The layer of ln-10 was thicker in the
two asthmatic groups while an increased thickness of lns-2 and -5 was only seen in allergic
asthmatics. The ln gamma2-chain, which is only found in ln 5, was exclusively expressed in epithelial
cells in association with epithelial injury and in the columnar epithelium of allergic asthmatics.
Conclusion: The uncoordinated production of chains of ln-5 in allergic asthma could have a
bearing on the poor epithelial cell anchorage in these patients.
Background
Asthma is a chronic inflammatory disease of the lungs
that may have allergic or non-allergic causes [1-3]. The
allergic type of asthma is characterized by the accumula-
tion of eosinophils, mast cells and lymphocytes of the
Th2-type in the bronchial mucosa, whereas the non-aller-
gic asthma has a substantial accumulation of neutrophils
in addition to eosinophils and mast cells [3]. Structural
changes and remodelling of the bronchial mucosa with
signs of epithelial injury, subepithelial basement thicken-
ing, smooth muscle hypertrophy, increased vasculariza-
tion and innervation are prominent features of the allergic
type of asthma and less prominent in the non-allergic type
[3].
Basement membranes (BMs) are built of cell-polymeriz-
ing networks of type IV collagens and laminins connected
by nidogen/entactin [4,5]. The major role of laminin for
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epithelial cells is to anchor them to BM for cell differenti-
ation and maintenance of cell function. Laminins are het-
erotrimeric molecules made up by one α, one β and one γ
chain. Until today we know of five α-chains, three β-
chains and three γ-chains. These chains combine into at
least 14 different Laminins (lns) i.e. lns 1–14. The distri-
bution of these Laminin isoforms varies between tissues,
but in most BMs more than one Laminin is present. The
chains of laminins have different regions that function by
binding to cellular receptor molecules among which the
most abundant are integrins, dystroglycan and the
recently characterized Lutheran blood group antigen
[4,6]. Several studies have shown the fundamental impor-
tance of intact Laminins in the BMs, since mutations may
give rise to serious diseases such as epidermolysis bullosa
in which the anchoring of the skin is grossly impaired [7].
Laminins also interact with many other cells and promote
migration and angiogenesis and their functions in tumour
invasion is one of the hot research topics of today [4].
The injury of the respiratory epithelium in the bronchi in
allergic asthmatics may be one of the mechanisms under-
lying bronchial hyperresponsiveness which is one of the
main features of asthma [8-11]. The mechanisms behind
the fragility of the epithelium in allergic asthmatics, i.e.
the propensity of the epithelium to shed from its anchor-
age to the subepithelial basement membrane (SEBM) and
basal cells have not been explained. Since one obligatory
component in this anchoring process is mediated by Lam-
inins, we hypothesized that uncoordinated production of
Laminin chains might contribute to weaken these anchor-
ing forces. Our aim was therefore to describe the presence
of the various Laminins in the epithelium and especially
SEBM of allergic asthmatics in comparison with non-aller-
gic asthmatics and healthy non-asthmatic controls.
Materials and methods
Subjects
Bronchial biopsies were collected from twenty-nine non-
smoking adults divided into the following groups: healthy
controls (n = 7), patients with allergic asthma (n = 11)
and patients with non-allergic asthma (n = 9) (Table 1).
All patients had a clinical asthma diagnosis, current
asthma symptoms and increased responsiveness to
inhaled methacholine. The allergic asthma patients all
had a positive skin prick test (≥ 3 mm) for at least one
common allergen (birch, timothy grass (Phleum pratense),
mugwort (Artemisia vulgaris), cat, dog, horse, house dust
mite (Dermatophagoides pteronyssinus), Cladosporium, and
Alternaria.) while the non-allergic asthma patients and the
controls all had a negative skin prick test. All patients with
allergic asthma were examined outside the birch and grass
pollen season (April to August).
All but one allergic and one non-allergic patient with
asthma were on regular treatment with inhaled glucocor-
ticosteroids (budesonide 200–800 g/day) and inhaled β2-
agonists as needed. The average use of inhaled glucocorti-
costeroids was similar in the two asthma groups. A more
detailed description of the study population has been pre-
sented in a previous report[3].
Bronchoscopy
The patients were given 10 mg diazepam (Stesolid®,
Dumex, Copenhagen, Denmark) orally and 0.5 mg atro-
pine (Atropin, NM Pharma, Stockholm, Sweden) subcuta-
neously 30 minutes before the investigation. The upper
airways were anaesthetized with lidocain hydrochloride
(Xylocain, Astra, Södertälje, Sweden). Using a flexible
fibre bronchoscope (Olympus P 20D) with a FB 15C 2,0
mm forceps (Olympus), two biopsies were taken from
each of three different airway levels in the right lung: (A)
in the upper lobe bronchus immediately after the division
Table 1: Patient characteristics (n or median (range))
Healthy control (n = 7) Allergic asthma (n = 11) Non-allergic asthma (n = 9)
Age (yr) 25 (22–43) 37 (29–63) 41 (17–62)
Sex (M/F) 2/5 2/9 2/7
FEV1 (% pred) 98 (71–120) 94 (72–109) 86 (72–97)
FVC (% pred) 98 (78–109) 100 (86–118) 87 (76–96)
Symptom score * 0 (0–1) 2 (0–4) 2 (1–2)
PEF-variability (%) 5 (3–9) 11 (6–22) 10 (5–20)
PC20 (mg/ml) - 2.7 (0.07–32) 8.7 (1.0–32)
Pollen allergy 0 9/11 0
Pet allergy 0 11/11 0
Mite allergy 0 4/11 0
Mould allergy 0 3/11 0
*number of symptoms recorded in a questionnaire during 2 weeks (9)Respiratory Research 2005, 6:110 http://respiratory-research.com/content/6/1/110
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from the main bronchus, (B) at the division between the
middle and lover lobe bronchi and (C) from the main
lower lobe divisions. The specimens were immediately
examined under a light microscope to ensure the presence
of a complete mucosa and fixed as described below. The
patients were instructed to take their regular asthma
sprays the morning of the bronchoscopy.
The study was conducted in accordance with the Declara-
tion of Helsinki and was approved by the ethics commit-
tee at the Faculty of Medicine at the University of Uppsala.
Immunohistochemistry
The expression of different Laminin chains in the epithe-
lium and in the subepithelial basement membrane was
studied in frozen sections by the use of monoclonal anti-
bodies and the alkaline phosphate-anti-alkaline phos-
phatase method (APAAP) visualization system. Mouse
monoclonal antibodies (MAbs) against the ln α1 chain
(clone 161 EB7)[12], ln α4 chain (clone 168FC10)[13], ln
α5 (clone 4C7) [14,15], ln β1 chain (clone 114DG.)[16],
ln β2 chain (clone C4, obtained from the hybridoma C4
developed by Joshua Sanes obtained from the Develop-
mental Studies hybridoma Bank developed under the aus-
pices of the NICHD and maintained by the University of
Iowa, Department of Biological Sciences, Iowa City, IA
52242), ln γ1 chain (113BC7), ln γ2 chain (clone D4B5)
[17] were produced and characterized as described earlier.
MAb against lns α2 and α3 chains (clones Lam M and
P3H9-2, respectively) were purchased from Chemicon
International, Temecula, California, USA.
The bronchial biopsy specimens were taken from the
upper lobe and frozen immediately in melting propane
previously cooled in liquid nitrogen and further processed
as described in detail previously [3]. Incubation with anti-
bodies to ln α1 chain (diluted 1:4 in PBS), ln α2 chain
(diluted 1:500 in PBS), ln α3 chain (diluted 1:1000 in
PBS) ln α4 chain (diluted 1:5 in PBS), ln α5 (diluted
1:300 in PBS), ln β1 chain (diluted 1:400 in PBS), ln β2
chain (diluted 1:750 in PBS), ln γ1 chain (diluted 1:400 in
PBS) and ln γ2 chain (diluted 1:1000 in PBS) were per-
formed at room temperature in a humid chamber for 20
h and terminated by two rinses in PBS. The bound anti-
bodies were visualized with the alkaline phosphates-anti-
alkaline phosphatase method (APAAP kit K670, Dakocy-
tomation, Glostrup, Denmark) using fast red substrate.
The sections were counterstained with Mayer's hematoxy-
lin (Merck; Darmstadt, Germany) for two minutes and
mounted with Faramount (S 3025, Dako). In the negative
controls, the primary antibodies were omitted.
Microscopic Evaluation of Sections
The Leica DMLB microscope (Wetzlar GmbH, Germany)
was equipped with a Leica Microsystems digital camera
(DC 300F) connected to a PC-computer. The images were
captured and saved in the computer for further evaluation
using the software package Qwin v2.7. In each biopsy two
subsequent sections were evaluated. The thickness of the
Laminin layers (in µm) was measured in immunolabeled
frozen sections using a X10 objective and the computer-
ized image analysis system after calibration with the aid of
a stage micrometer. Measurements were carried out on
100 randomly selected sites per section and the results
expressed as the mean of these measurements. The varia-
tion in estimation of structural changes between the two
microscopic sections varied between 4–8% (% coefficient
of variation). All slides were assessed by an observer
blinded to the diagnosis of the patient.
Statistics
All statistics were calculated using non-parametric tests.
Comparisons between the three groups were initially per-
formed by means of analysis of variance (Kruskal-Wallis
test). In case of significance paired group comparisons
were performed with the Mann-Whitney U-test. A p-value
of <0.05 was regarded as statistically significant.
Results
Ln α-chain
With MAb against ln α1-chain we saw some weak patchy
staining of the SEBM in biopsies from patients with aller-
gic asthma, but not in the biopsies of healthy subjects or
of subjects with non-allergic asthma. Alfa2-chains were
found in the SEBM and were significantly thicker in biop-
sies from allergic asthmatics as compared to non-allergic
asthmatics and healthy controls (table 2). The α3-chain
was also found in the SEBM and the layer was significantly
thicker in biopsies from allergic asthmatics compared to
non-allergic asthmatics and controls (Figure 1, table 2).
No staining of the epithelium was discerned with the anti-
bodies against the α3-chain. No staining of the SEBM or
epithelium was found with antibodies against α4-chains.
The staining of SEBM with antibodies against the α5-
chain showed a thicker layer in the allergic than in the
non-allergic asthmatics. The layer α5 was also thicker in
the non-allergic asthmatics than in the controls (Figure 2).
Ln β-chains
Ln β1-chains were seen in the SEBM and the thickness was
significantly higher in biopsies from allergic asthmatics as
compared to non-allergics and healthy controls (Table 2).
The staining of SEBM with antibodies against the β2-chain
showed a slight increase of the thickness in allergic asth-
matics as compared to non-allergic asthmatics and con-
trols, but with no difference between non-allergic
asthmatics and controls (Table 2).Respiratory Research 2005, 6:110 http://respiratory-research.com/content/6/1/110
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Ln γ-chains
Staining of the biopsy with antibodies against the ln γ1-
chain revealed an increased thickness in the SEBM in both
allergic and non-allergic asthma as compared to controls
and a much thicker layer in allergic asthmatics as com-
pared to non-allergics (Figure 3). The staining of the bron-
chial mucosa with antibodies against the γ2-chain
revealed a thicker layer in the SEBM in allergic asthmatics
as compared to both non-allergic asthmatics and controls
(Figure 4, Table 2). The antibodies also stained the epithe-
lium. Thus, as shown in the figure the staining was found
both in the apical part of the columnar epithelium and in
the basal cells. Staining of the apical part of the columnar
epithelium was only found in intact epithelium from
allergic asthmatics, whereas staining of the basal cells was
seen in all three groups in areas of epithelial injury. A
close correlation was also found between the epithelial
integrity in the three study groups and the thickness of the
ln γ2-chain (figure 5).
When combining the information on individual laminin
chains, we found that lns-2 (α2β1γ1),-5 (α3β3γ2) and -10
(α5β1γ1) were the main laminins of the SEBM. The layer
of ln-10 was thicker in the two asthmatic groups while an
increased thickness of lns-2 and -5 was only seen in aller-
gic asthmatics. The staining of ln γ2-chain in the absence
of ln α3 in epithelial cells does not fit with any presently
known laminin.
Discussion
This study has systematically investigated the presence of
most Laminin chains in the epithelium and SEBM of both
allergic and non-allergic asthmatics. The primary object
was to test the hypothesis that differences in Laminin
chain compositions in SEBM might help explain the phe-
nomenon of epithelial fragility and shedding as is typi-
cally seen in biopsies of allergic asthmatics [3]. We found
several alterations in the Laminin chain composition in
the SEBM of allergic asthmatics. Most of these differences
seemed quantitative rather than qualitative. Unexpectedly
we found distinct qualitative differences with respect to
ln-5 chain compositions that may have a bearing on the
poorer anchorage of epithelial cells to BM in allergic
asthma. The finding of a close correlation between ln γ2-
chain deposition and epithelial injury indeed emphasises
the close relationship between laminin chain production
and epithelial injury as is observed in certain subjects with
asthma. However, the relationship does not tell us
whether epithelial shedding is a cause of the uncoordi-
nated laminin chain production or whether the uncoordi-
nated production is a consequence of the repair processes
induced by epithelial injury.
The unexpected findings were both related to the ln γ2-
chain staining. According to the present knowledge the
γ2-chain is only found as part of ln-5 (α3β3γ2) [4,18]. In
our biopsies we found exclusive staining with the anti-
bodies against the γ2-chain in the epithelium, with no
sign of simultaneous staining with antibodies against the
α3-chain. The epithelium staining could be a reflection of
the fact that airways epithelium is a producer of the ln γ2-
chain and that the staining reflects the deposition of non-
secreted protein. It was of particular interest that we found
accumulation of immunoreactivity in the apical part of
intact columnar epithelium in allergic asthmatics, but not
in the other two groups, whereas staining of the basal cells
were seen in all three groups in areas of epithelial destruc-
tion. This staining was observed without any concomitant
staining of the complementary ln-5 α3 chain, which sug-
gests an uncoordinated production of the γ2 chain in the
epithelium of allergic asthmatics resulting in the intracel-
lular accumulation of the γ2 chain, since the extracellular
secretion probably requires the assembly of the heterot-
rimeric molecule [18]. The staining pattern could also
Table 2: The thickness of various laminin chains in SEBM (µm)
Laminin chain Healthy controls Allergic asthma Non-allergic asthma
α1-chain No staining Patchy, weak staining No staining
α2-chain 1.94 (1.70–2.20) 2.83 (2.50–3.30)**, ‡‡‡ 2.19 (1.8–2.90)
α3-chain 2.46 (1.80–3.10) 3.77 (3.30–4.40)***, ‡‡‡ 2.61 (2.20–3.10)
α4-chain No staining No staining No staining
α5-chain 2.31 (1.90–2.50) 4.10 (3.30–4.60)***, ‡‡‡ 2.86 (2.40–3.50) **
β1-chain 2.13 (1.60–2.80) 4.84 (4.10–5.50)***, ‡‡‡ 3.29 (3.10–3.80) ***
β2-chain 1.93 (1.60–2.60) 2.34 (2.10–2.800)*, ‡‡ 2.04 (1.80–2.300)
γ1-chain 2.47 (1.90–3.00) 4.86 (4.20–5.40) ***, ‡‡‡ 3.49 (2.90–3.90) ***
γ2-chain 2.03 (1.70–2.40) 2.96 (2.60–3.50)**, ‡‡‡ 2.36 (2.00–2.80)
Results are given as medians and interquartile ranges. Differences between groups were calculated by the Mann-Whitney non-parametric test and 
statistical differences shown in the table. **, *** indicate p < 0.01 and p < 0.001, respectively, in the comparison between either of the two asthma 
groups with the results of the healthy controls. ‡, ‡‡, ‡‡‡ indicate p < 0.05, <0.01 and 0.001, respectively, in the comparison between the two 
asthma groups.Respiratory Research 2005, 6:110 http://respiratory-research.com/content/6/1/110
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indicate the presence of a hitherto unrecognised Laminin
or alternatively that the α3 chain had been proteolytically
modified with the loss of the particular epitope recog-
nized by our monoclonal antibodies [19].
The intense staining of the cytoplasm of basal cells in
areas of epithelial injury suggests that the basal cells are
producers of the ln γ2 chain and probably also of the
whole heterotrimeric complex of ln-5, although no stain-
ing of the other two chains was observed. Indeed, sole
expression of ln γ2 chain has been shown in invading
tumour cells[4,20], which shows that uncoordinated pro-
duction of the three ln-5 chains may take place under cer-
tain conditions. It is also of interest that Lappi-Blanco et
al. in a recent report found ln γ2 chain expression to be
increased in regenerating epithelial cells and also found γ2
chain in basal cells of normal bronchus [21]. These results
Cryostat sections of bronchial biopsies stained with antibodies against the ln α3 chain Figure 1
Cryostat sections of bronchial biopsies stained with antibodies against the ln α3 chain. Allergic asthma (A), non-allergic asthma 
(B) and healthy control (C) (original magnification ×170). The comparison of the thickness of SEBM is shown and the significant 
differences between the groups shown in the figure. Mayer's hematoxylin.
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suggest that our findings of intense staining seen in the
basal cells at areas of tissue injury may be a sign of re-epi-
thelialization and repair.
The SEBM showed the presence of mainly three Laminins
i.e. ln-5 (α3β3γ2), ln-10 (α5β1γ1) and ln-2 (α2β1γ1). The
two former were expected based on earlier findings [4,22],
whereas the presence of ln-2 mostly is associated with
BMs surrounding tissues such as muscles and nerves [23].
In a previous report we indicated the wide presence of α1-
chains in SEBM, which is seemingly contrasted by the
present results[24]. Those results, however, were based on
the false assumption that the monoclonal antibody 4C7
specifically recognizes α1-chains, which is not the case.
The 4C7 antibody only recognizes the α5-chains [14,15].
As was previously found the thickness of the Laminin
layer in the SEBM was increased in allergic asthmatics as
compared to both non-allergic asthmatics or healthy
Cryostat sections of bronchial biopsies stained with antibodies against the ln α5 chain Figure 2
Cryostat sections of bronchial biopsies stained with antibodies against the ln α5 chain. Allergic asthma (A), non-allergic asthma 
(B) and healthy control (C) (original magnification ×170). The comparison of the thickness of SEBM is shown and the significant 
differences between the groups shown in the figure. Mayer's hematoxylin.
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controls [3]. This difference was most obvious for ln-10,
since also the thickness found in non-allergic asthmatics
was increased as compared to healthy non-asthmatic con-
trols. This was contrasted by the increased thickness of ln-
5 and -2, which was only seen in allergic asthmatics. These
differences, therefore suggest qualitative differences in the
production of various chains in allergic and non-allergic
asthmatics, which may relate to the differences in the
inflammatory processes going on in these two diseases.
The allergic asthma being eosinophil-mast cell-Th2 driven
and the non-allergic asthma being more neutrophil-mast
cell driven, although eosinophils are also present at
increased amounts in the non-allergic asthma [3].
As mentioned above the primary aim of this work was to
test the hypothesis that an imbalance in Laminin chain
production might explain the observed epithelial cell loss
in allergic asthmatics. This hypothesis is seemingly refuted
Cryostat sections of bronchial biopsies stained with antibodies against the ln γ1 chain Figure 3
Cryostat sections of bronchial biopsies stained with antibodies against the ln γ1 chain. Allergic asthma (A), non-allergic asthma 
(B) and healthy control (C) (original magnification ×170). The comparison of the thickness of SEBM is shown and the significant 
differences between the groups shown in the figure. Mayer's hematoxylin.
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by our data, since others have shown that ln-5 induces the
formation of hemidesmosomes [25], which actually
promote stable cell:matrix adhesion. Another interesting
property of ln-5 is the biological activity of the proteolyt-
ically modified fragments, which might modify cellular
behaviours [26]. However, it should also be noted that
mutations or modifications of any of the chains of ln-5 are
associated with severe disease due to separation of epithe-
lia from the underlying basement membrane [7]. Thus,
we cannot exclude any processing of ln-5 in the inflamed
Cryostat sections of bronchial biopsies stained with antibodies against the ln γ2 chain Figure 4
Cryostat sections of bronchial biopsies stained with antibodies against the ln γ2 chain. Allergic asthma (A), non-allergic asthma 
(B) and healthy control (C) (original magnification ×170). As shown in the figure epithelial staining was found both in the apical 
part of the columnar epithelium and in the basal cells. Staining of the apical part of the columnar epithelium was only found in 
intact epithelium from allergic asthmatics. The comparison of the thickness of SEBM is shown and the significant differences 
between the groups shown in the figure. Mayer's hematoxylin.
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tissue of allergic asthma as an explanation of poor anchor-
age of the epithelial cells in the bronchi to the underlying
basement membrane.
Conclusion
We conclude that Laminin chain deposition in the epithe-
lium and SEBM of allergic and non-allergic asthmatics
differs in qualitative and quantitative terms and that there
is a close relationship between ln γ2-chain deposition and
epithelial injury. The uncoordinated production of the
chains of ln-5 in the epithelium of allergic asthmatics may
be of particular interest, since ln-5 promotes the
formation of hemidesmosomes, which promote stable
cell matrix adhesion.
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